Role of lycopene in the control of ROS-mediated cell growth: implications in cancer prevention

P Palozza1, N Parrone, R Simone

  • 1Institute of General Pathology, Catholic University, School of Medicine, Rome, Italy. p.palozza@rm.unicatt.it

Insights

Lycopene, found in tomatoes, may protect against chronic diseases by acting as a redox agent. It modulates reactive oxygen species (ROS) to influence cell growth, differentiation, and apoptosis, potentially preventing oxidative damage and cancer.

Area of Science:

  • Nutritional Science
  • Molecular Biology
  • Cell Biology

Background:

  • Dietary lycopene from tomatoes is linked to reduced chronic disease risk, including cancer.
  • Potential mechanisms include immune modulation and gap junction communication.
  • Emerging evidence suggests lycopene acts as a redox agent, controlling reactive oxygen species (ROS) and cell growth.

Purpose of the Study:

  • To review the role of lycopene as a redox agent in cell proliferation, differentiation, and apoptosis.
  • To examine lycopene's prevention of oxidative damage and its influence on cell growth.
  • To explore lycopene's modulation of redox-sensitive molecular targets in cell signaling.

Main Methods:

  • Literature review of existing evidence on lycopene's biological activities.
  • Focus on lycopene's interaction with reactive oxygen species (ROS).
  • Analysis of lycopene's effects on cellular processes and signaling pathways.

Main Results:

  • Lycopene acts as a redox agent, influencing cell proliferation, differentiation, and apoptosis.
  • It prevents cellular oxidative damage and modulates cell growth.
  • Lycopene affects key redox-sensitive signaling molecules including growth factors, transcription factors (NF-kB, AP-1), and cytokines.

Conclusions:

  • Lycopene's redox properties are central to its beneficial effects on cell biology.
  • It plays a significant role in regulating cell growth and preventing oxidative stress.
  • Lycopene may have a role in cancer prevention through its redox modulation of cellular processes.

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...